ALPHA BIOPHARMA 江苏晨泰医药科技有限公司 Mediaroom - PR Newswire APAC

Search

ALPHA BIOPHARMA 江苏晨泰医药科技有限公司

Latest News

Alpha Biopharma Submits New Drug Application for Zorifertinib, a Next-Generation EGFR-TKI to Treat EGFR-mutated NSCLC Patients with CNS Metastases

SHANGHAI, Jan. 29, 2023 /PRNewswire/ -- Alpha Biopharma, a developer of innovative drugs, announces...

2023-01-30 10:00 1983

Alpha Biopharma Announces Completion of its EVEREST Phase II/III Clinical Study of Zorifertinib in Non-Small Cell Lung Cancer Patients with Central Nervous System Metastases

* Zorifertinib is a next generation EGFR-TKI with full Blood Brain Barrier penetration targeting ...

2022-08-25 10:00 1766